The U.S. Food and Drug Administration (FDA) has approved Lexicon Pharmaceuticals Inc's drug for a broad treatment of heart failure, including in adult patients with type 2 diabetes, the company said on Friday.
Lexicon, which plans to launch the drug by the end of June, said the medicine's wholesale price is expected to be on par with existing branded heart failure medications.
Sotagliflozin presents a unique proposition in heart failure, especially considering the drug's differentiated benefit in hospitalized patients, compared with existing treatments, Piper Sandler analyst Yasmeen Rahimi said ahead of the approval.Lexicon partnered with French drugmaker Sanofi SA
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
TransCon PTH Nears US Approval for Hypoparathyroidism?Palopegteriparatide is a potential long-term therapy for adults with hypoparathyroidism, new findings suggest.
Read more »
COVID-19 pill Paxlovid gets full FDA approval after over a year of emergency useThursday’s action means the drug has now been fully vetted by the U.S. government and can remain on the market indefinitely.
Read more »
Paxlovid, Pfizer's COVID-19 pill, gets full FDA approvalU.S. health regulators have given full approval to Pfizer’s COVID-19 pill Paxlovid.
Read more »
Elon Musk’s Neuralink gets FDA approval for human test of brain implantsNeuralink is developing a brain implant it hopes will help paralyzed people walk again and cure other neurological ailments.
Read more »
Elon Musk's Neuralink gets FDA approval for study of brain implants in humansElon Musk's brain-implant company Neuralink on Thursday said it had received the U.S. Food and Drug Administration's (FDA) approval to launch its first-in-human clinical study.
Read more »
Pfizer's Paxlovid still free, for now, after FDA grants full approval to COVID drugThe Biden administration will continue to manage the distribution of free courses of Pfizer's Paxlovid treatment for COVID-19 for at least another few months, the drugmaker said, even after the FDA granted Pfizer full approval Thursday to market the pills.
Read more »